These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 8004818)

  • 1. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
    Hoon DS; Okun E; Banez M; Irie RF; Morton DL
    Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.
    Iwasaki K; Rogers LR; Estes ML; Barna BP
    Neurosurgery; 1993 Sep; 33(3):489-93; discussion 493-4. PubMed ID: 8413882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
    Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
    Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
    Koo AS; Armstrong C; Bochner B; Shimabukuro T; Tso CL; deKernion JB; Belldegrum A
    Cancer Immunol Immunother; 1992; 35(2):97-105. PubMed ID: 1596939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells.
    Swerlick RA; Garcia-Gonzalez E; Kubota Y; Xu YL; Lawley TJ
    J Invest Dermatol; 1991 Aug; 97(2):190-6. PubMed ID: 1906507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro: in combination with interferon-alpha, tumor necrosis factor-alpha or interleukin-2.
    Cheon J; Chung DJ; Kim JJ; Koh SK; Sohn J
    Int J Urol; 1996 May; 3(3):196-201. PubMed ID: 8776617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].
    Gohji K; Hamami G; Kamidono S
    Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 (ICAM-1) on renal cell cancer. De novo expression and modulation by cytokines on renal cell cancer cell lines].
    Tomita Y; Nishiyama T; Sato S; Fujiwara M
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):232-8. PubMed ID: 1674973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro.
    Angus R; Collins CM; Symes MO
    Eur J Cancer; 1993; 29A(13):1879-85. PubMed ID: 8260246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
    van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
    Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.
    van Valen F; Winkelmann W; Burdach S; Göbel U; Jürgens H
    J Cancer Res Clin Oncol; 1993; 119(10):615-21. PubMed ID: 8335680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.